Detailed answers about ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP, including incorporation, status, business activity, and accounts information.
When was ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP founded?
ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP was officially incorporated on 17 August 2020 and is registered under company number LP021179. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP?
Limited Partnership. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP?
ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What is ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP's registered address?
The registered office address of ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP is 1 ST. JAMES'S MARKET, LONDON, ENGLAND, SW1Y 4AH. This is the official address filed with Companies House for legal and statutory correspondence.
Is ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP financially stable?
Financial accounts for ABINGWORTH CLINICAL CO-DEVELOPMENT FUND 2 LP are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.